Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 4, 2016Virtual Press Office and PR Newswire: General Trade show news
New research presented this week at Experimental Biology 2016 (EB 2016) expands on the current body of evidence supporting the link between dried plums (prunes) and bone health in post-menopausal...
-
Apr 4, 2016Virtual Press Office and PR Newswire: General Trade show news
Diebold, Incorporated (NYSE: DBD) is showcasing one of its newest mobile-driven banking concepts, along with an industry-leading security application from Cryptera, at Money 20/20 Europe....
-
Apr 3, 2016Virtual Press Office and PR Newswire: General Trade show news
BIGaVu, LLC, a San Diego, CA start-up, today announced that it will be unveiling prototypes of its IoT focused "smart comfort device" that utilize its proprietary technology in Laguna Niguel, CA...
-
Apr 3, 2016Virtual Press Office and PR Newswire: General Trade show news
Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing investigational drugs for treating mitochondrial dysfunction, announced promising results from the Phase 1...
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Findings from a clinical trial comparing Victoza® (liraglutide [rDNA origin] injection) and sitagliptin (100 mg), both in combination with metformin, demonstrated that switching from sitagliptin...
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced findings from two new studies demonstrating the clinical utility of the Afirma...
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Findings from the first phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment with semaglutide, administered once...
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the results of a new interim analysis of data from the ongoing phase III RE-VERSE AD™ patient study that showed a single 5g dose of...
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the randomized PARTNER...
-
Apr 1, 2016Virtual Press Office and PR Newswire: General Trade show news
Mary Catherine (Kitty) Van Bortel, president of Van Bortel Subaru in Victor, New York, was named the 2016 TIME Dealer of the Year today. Van Bortel received this highest honor out of a select...